4D Molecular Therapeutics, Inc. · NASDAQ:FDMT

BVF PARTNERS L P/IL reported a 9.99% stake in 4D Molecular Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2026 · Filed Nov 16, 2026

BVF PARTNERS L P/IL reported a 9.99% stake in 4D Molecular Therapeutics, Inc., 5,811,860 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
5,811,860
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P7.30%4,265,045
BVF I GP LLC7.30%4,265,045
BIOTECHNOLOGY VALUE FUND II LP2.10%1,153,481
BVF II GP LLC2.10%1,153,481
Biotechnology Value Trading Fund OS LP0.60%336,458
BVF Partners OS Ltd.0.60%336,458
BVF GP HOLDINGS LLC9.30%5,418,526
BVF PARTNERS L P/IL9.99%5,811,860
BVF INC/IL9.99%5,811,860
LAMPERT MARK N9.99%5,811,860

Source

Download original · View original at SEC

Related